Market closedNon-fractional
Organon/OGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Organon
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Ticker
OGN
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Jersey City, United States
Employees
10,000
Website
www.organon.com
Organon Metrics
BasicAdvanced
$5.7B
Market cap
5.41
P/E ratio
$4.08
EPS
0.77
Beta
$1.12
Dividend rate
5.07%
Dividend yield
Price and volume
Market cap
$5.7B
Beta
0.77
Dividend rate
$1.12
Financial strength
Current ratio
1.649
Quick ratio
0.837
Long term debt to equity
18,135.417
Total debt to equity
18,154.167
Dividend payout ratio (TTM)
27.79%
Interest coverage (TTM)
2.56%
Management effectiveness
Return on assets (TTM)
7.44%
Return on equity (TTM)
-303.92%
Valuation
Price to earnings (TTM)
5.412
Price to revenue (TTM)
0.889
Price to book
117.71
Price to tangible book (TTM)
-1.07
Price to free cash flow (TTM)
12.315
Dividend yield (TTM)
5.07%
Growth
Revenue change (TTM)
3.29%
Earnings per share change (TTM)
39.65%
3-year revenue growth (CAGR)
0.47%
3-year earnings per share growth (CAGR)
-17.72%
What the Analysts think about Organon
Analyst Ratings
Majority rating from 10 analysts.
Organon Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.6B
1.50%
Net income
$201M
-63.19%
Profit margin
12.39%
-63.73%
Organon Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.31
$0.87
$0.88
$1.22
-
Expected
$1.01
$1.06
$0.83
$0.97
$1.17
Surprise
30.13%
-17.66%
6.02%
25.69%
-
Organon News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Organon stock?
Organon (OGN) has a market cap of $5.7B as of July 26, 2024.
What is the P/E ratio for Organon stock?
The price to earnings (P/E) ratio for Organon (OGN) stock is 5.41 as of July 26, 2024.
Does Organon stock pay dividends?
Yes, the Organon (OGN) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $1.12 and the yield is 5.07%. Organon has a payout ratio of 27.79% on a trailing twelve-month basis.
When is the next Organon dividend payment date?
The next Organon (OGN) dividend payment date is unconfirmed.
What is the beta indicator for Organon?
Organon (OGN) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Organon stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.